OmniActive’s capsicum and Salacia extracts have both received self-affirmed Generally Recognized as Safe status by an expert panel.
Photo © iStockphoto.com/efired
Two of OmniActive’s (Morristown, NJ) proprietary ingredients, its Capsimax capsicum extract and its OmniLean Salacia extract, have now received self-affirmed Generally Recognized as Safe (GRAS) status, the firm reports. Both ingredients were determined to be GRAS in accordance with FDA safety criteria by expert panels.
OmniLean, which OmniActive has dubbed a “metabolic synergizer,” is designed to help support metabolic health, with a recent study suggesting it may reduce post-prandial insulin and blood glucose.
“OmniLean is a novel, differentiated ingredient with huge opportunity due to its formula flexibility and versatility in the metabolic health, weight management, and satiety categories,” said Lynda M. Doyle, senior vice president of global marketing for OmniActive. “OmniLean comes backed by OmniActive’s robust clinical program and GRAS self-affirmation, which positions it as a unique, safe, and effective ingredient.”
Meanwhile, Capsimax capsicum extract delivers capsaicinoids “without the oral and gastric burning sensation of unprotected red hot peppers,” according to OmniActive.
“Capsimax is a category-creating ingredient,” said Doyle. “And with new Capsimax science coming out of our robust clinical program, as well as gaining GRAS self-affirmation, Capsimax remains a unique ingredient for sports nutrition, weight management, and healthy, active lifestyles.”
Read more:
CurcuWin Curcumin Obtains Self-Affirmed GRAS
Lutein and Zeaxanthin Trade Organization Born Out of Kemin, OmniActive Legal Battle
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.